Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function. [electronic resource]
Producer: 20070201Description: 1255-8 p. digitalISSN:- 1464-4096
- Brachytherapy -- adverse effects
- Erectile Dysfunction -- drug therapy
- Humans
- Male
- Middle Aged
- Phosphodiesterase Inhibitors -- therapeutic use
- Piperazines -- therapeutic use
- Prospective Studies
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- complications
- Purines
- Retrospective Studies
- Sildenafil Citrate
- Sulfones
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.